Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3966698
Max Phase: Preclinical
Molecular Formula: C34H32O7
Molecular Weight: 552.62
Molecule Type: Small molecule
Associated Items:
ID: ALA3966698
Max Phase: Preclinical
Molecular Formula: C34H32O7
Molecular Weight: 552.62
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)=CCc1c(O)c(C(=O)CC(C)COC(=O)/C=C/c2ccccc2)c(O)c2c(-c3ccccc3)cc(=O)oc12
Standard InChI: InChI=1S/C34H32O7/c1-21(2)14-16-25-32(38)31(27(35)18-22(3)20-40-28(36)17-15-23-10-6-4-7-11-23)33(39)30-26(19-29(37)41-34(25)30)24-12-8-5-9-13-24/h4-15,17,19,22,38-39H,16,18,20H2,1-3H3/b17-15+
Standard InChI Key: RYOCGBKLTMGWME-BMRADRMJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 552.62 | Molecular Weight (Monoisotopic): 552.2148 | AlogP: 6.85 | #Rotatable Bonds: 10 |
Polar Surface Area: 114.04 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 6.96 | CX Basic pKa: | CX LogP: 8.30 | CX LogD: 7.69 |
Aromatic Rings: 4 | Heavy Atoms: 41 | QED Weighted: 0.07 | Np Likeness Score: 1.32 |
1. Franchin M, Rosalen PL, da Cunha MG, Silva RL, Colón DF, Bassi GS, de Alencar SM, Ikegaki M, Alves-Filho JC, Cunha FQ, Beutler JA, Cunha TM.. (2016) Cinnamoyloxy-mammeisin Isolated from Geopropolis Attenuates Inflammatory Process by Inhibiting Cytokine Production: Involvement of MAPK, AP-1, and NF-κB., 79 (7): [PMID:27367493] [10.1021/acs.jnatprod.6b00263] |
2. da Cunha MG, Ramos-Junior ES, Franchin M, Taira TM, Beutler JA, Franco GCN, Ikegaki M, de Alencar SM, Fukada SY, Rosalen PL.. (2017) Effects of Cinnamoyloxy-mammeisin from Geopropolis on Osteoclast Differentiation and Porphyromonas gingivalis-Induced Periodontitis., 80 (6): [PMID:28570825] [10.1021/acs.jnatprod.7b00194] |
Source(1):